Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
DA Davidson initiated coverage of Vesper Healthcare Acquisition Corp. with a rating of Buy and set a new price target of $15.50
The Benchmark Company initiated coverage of Vesper Healthcare Acquisition Corp. with a rating of Buy and set a new price target of $16.00
Benchmark initiated coverage of Vesper Healthcare with a rating of Buy and set a new price target of $16.00
CHICAGO and PARK CITY, Utah, May 5, 2021 /PRNewswire/ -- Linden Capital Partners ("Linden") and DW Healthcare Partners IV, LP ("DW Healthcare Partners"), both private equity firms focused exclusively on the healthcare sector, announced today the completion of the merger of Edge Systems, LLC ("HydraFacial"), a category-creating beauty health company, with Vesper Healthcare Acquisition Corp. (NASDAQ:VSPR) ("Vesper" or "Vesper Healthcare"). Vesper is a special purpose acquisition company ("SPAC") led by former Allergan CEO Brent Saunders. As a result of the transaction, the combined company, now known as The Beauty Health Company ("BeautyHealth" or the "Company"), is expected to trade on the Na
First Quarter 2021 Preliminary Financial Highlights: Q1 net sales of $47 million compared to $33 million in Q1 2020 and $35 million in Q1 2019 Q1 net sales in the Americas region of $31 million, or 66% of total net sales, compared to $24 million in Q1 2020 and $27 million in Q1 2019 Q1 net sales in the EMEA and APAC regions of $16 million, or 34% of total sales, compared to $9 million in Q1 2020 and $8 million in Q1 2019 The HydraFacial® Company ("HydraFacial," or the "Company"), an experiential category-creating beauty health company, today announced preliminary net sales for the quarter ended March 31, 2021. The Company has not yet completed the quarter-end review and expects to r
MIAMI BEACH, Fla. & LONG BEACH, Calif.--(BUSINESS WIRE)--The HydraFacial® Company (“HydraFacial,” or the “Company”), a category-creating beauty health company, today announced preliminary net sales for the fiscal year ended December 31, 2020. HydraFacial currently expects net sales for fiscal year 2020 to approximate $119 million. The Company’s previous expectation for net sales, provided on December 9, 2020, was approximately $115 million. The Company has not yet completed the year-end audit and expects to report full results for fiscal year 2020 at a future date. The previously announced business combination with Vesper Healthcare (NASDAQ: VSPR) remains on track to be completed
4 - Beauty Health Co (0001818093) (Issuer)
4 - Beauty Health Co (0001818093) (Issuer)
4 - Beauty Health Co (0001818093) (Issuer)
4 - Beauty Health Co (0001818093) (Issuer)
8-K - Beauty Health Co (0001818093) (Filer)
SC 13D/A - Beauty Health Co (0001818093) (Subject)
SC 13D - Beauty Health Co (0001818093) (Subject)
SC 13G - Vesper Healthcare Acquisition Corp. (0001818093) (Subject)